Dagmar Koschnitzki currently serves as Head of Quality API Biosynthesis at Sanofi, following a tenure as QA Manager at the same company. From April 2018 to July 2022, Dagmar was QA Microbiology Manager at Novartis, overseeing both Drug Substance and Drug Product, acting as a key connection between Quality Control and Production, and serving as a subject matter expert during audits. Prior experience includes a Postdoctoral Researcher role at Ludwig-Maximilians Universität München, focusing on bacterial cell dynamics, and a Doctoral Researcher position at Deutsches Zentrum für Luft-und Raumfahrt e.V., investigating radiation tolerance in Ignicoccus species. Dagmar holds a Ph.D. in Microbiology from the University of Regensburg and both a Master of Science and Bachelor of Science in Biological Sciences and Biology from the University of Cologne.
This person is not in any teams
This person is not in any offices